Patrik Frei, PhD

Patrik is the founder and CEO of Venture Valuation Inc., Switzerland, the company he started in 1999, and the Novartis Venture Fund was the first client. Since then, he has been involved in over 1,000 asset and company valuations around the globe for investors, as well as for Biotech, Pharma, and Medtech companies. Valuations are provided for financing rounds, M&A, licensing deals, fairness opinions, tax, and compliance reasons. Venture Valuation runs two additional services/businesses: (1) Biotechgate, a global business development database (www.biotechgate.com) with licensing deal terms, financing rounds, investors, clinical trials, and M&A transactions; and (2) HelloPartnering (www.hellopartnering.com), a leading one2one partnering software including the Biotechgate Digital Partnering event (www.digitalpartnering.com). Patrik graduated from the Business University of St. Gallen in Finance and completed his Ph.D thesis at the Swiss Federal Institute of Technology, EPFL in Lausanne. Patrik has experience as a board member of public and private companies, has published numerous articles, and provides valuation workshops around the world. Patrik graduated from the Business University of St. Gallen with a degree in Finance and completed his PhD thesis at the Swiss Federal Institute of Technology, EPFL, in Lausanne. Patrik has experience as a board member of public and private companies, published numerous articles, and provides valuation workshops around the world.